Corpectomy Surgery in India
Get Corpectomy Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Corpectomy Surgery in UAE
Corpectomy Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Corpectomy is a complex spinal decompression surgery in which one or more vertebral bodies — along with adjacent intervertebral discs — are surgically removed to relieve critical pressure on the spinal cord or nerve roots caused by trauma, tumour, infection, or degenerative disease; the excised segment is then reconstructed with a structural bone graft or titanium cage and stabilised with instrumented fusion. Reported clinical success rates range from 85–93% for neurological improvement when performed by high-volume spinal surgeons, making patient selection and surgical expertise the most decisive variables. GAF Healthcare connects international patients to JCI- and NABH-accredited centres in India and JCI- and DHA-licensed hospitals in Dubai and Abu Dhabi, offering end-to-end coordination so patients receive world-class spinal care at a fraction of Western costs.
Hospital Stay: 5–10 days (ICU: 1–2 days; general ward: 4–8 days depending on cervical vs. thoracolumbar approach and neurological status) • Total Stay in Country (Fit-to-Fly): 4–8 weeks (short-haul economy permissible at 4–5 weeks post-op with cervical brace; long-haul flights typically cleared at 6–8 weeks pending surgeon sign-off, compression stocking protocol, and LMWH prophylaxis plan) • Success Rate: 85–93% (neurological recovery and pain relief at 12-month follow-up; fusion success rate >95% at 24 months with modern titanium cage and pedicle-screw constructs)
What Is It?
Corpectomy addresses pathology within the vertebral body itself — a clinical situation where simple discectomy is insufficient because the bony architecture of the vertebra is compromised, collapsed, or directly compressing the spinal cord. The most common indications include multilevel cervical spondylotic myelopathy (CSM), burst fractures of the thoracolumbar spine, vertebral osteomyelitis or tuberculous spondylitis (Pott's disease), primary or metastatic vertebral tumours, and severe ossification of the posterior longitudinal ligament (OPLL). When the vertebral body fails structurally or when pathological tissue occupies the central canal, the spinal cord endures chronic compressive myelopathy or acute neurological deterioration that manifests as limb weakness, spastic gait, bladder or bowel dysfunction, and neuropathic pain — deficits that progress irreversibly if surgical decompression is delayed beyond critical thresholds.
The physiological consequence of untreated compressive myelopathy is ischaemic injury to the anterior two-thirds of the spinal cord — the territory supplied by the anterior spinal artery — resulting in loss of motor and autonomic function while dorsal-column sensory pathways may be partially preserved. Nurick Grade and the modified Japanese Orthopaedic Association (mJOA) score are the standard tools used to quantify myelopathy severity and to benchmark neurological recovery after surgery. In oncological cases, the Spinal Instability Neoplastic Score (SINS) guides the surgical versus non-surgical decision, while the Tomita and Tokuhashi scoring systems inform the extent of resection planned.
The standard of care for corpectomy has evolved significantly: modern practice integrates intraoperative neuromonitoring (IONM) using continuous somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs) to provide real-time alerts that allow the surgeon to modify technique and prevent iatrogenic cord injury. Navigation-assisted and robotic-arm-guided screw placement (e.g., Mazor X Stealth Edition, ROSA Spine) further reduces implant malposition rates to under 1.5%, a benchmark routinely achieved at the tertiary spinal centres affiliated with GAF Healthcare in India and the UAE.
Candidates
• ELIGIBLE — Neurological indications: Patients with confirmed cervical spondylotic myelopathy (CSM) at Nurick Grade 2 or higher, or mJOA score ≤14, who have failed ≥6 weeks of conservative management including structured physiotherapy and anti-inflammatory pharmacotherapy
• ELIGIBLE — Structural indications: Burst fractures with >50% loss of vertebral body height, canal compromise >50%, or neurological deficit; AO Spine Type C morphology fractures
• ELIGIBLE — Oncological indications: Single or limited-level primary vertebral tumours (e.g., chordoma, giant cell tumour); solitary or oligometastatic disease with SINS ≥7 and a projected survival >3 months; post-radiation vertebral collapse
• ELIGIBLE — Infectious indications: Pyogenic or tuberculous vertebral osteomyelitis with epidural abscess formation, progressive neurological deficit, or spinal instability despite appropriate antibiotic/antitubercular therapy
• ELIGIBLE — Congenital/degenerative: Severe OPLL occupying >60% of the canal at the level of maximum compression; failed posterior decompression (laminoplasty/laminectomy) with residual anterior compression
• REQUIRED PRE-OPERATIVE DIAGNOSTICS: MRI spine (T1, T2, STIR sequences) — mandatory; CT myelogram if MRI is contraindicated; CT spine with fine-cut reconstruction for surgical planning and cage sizing; standing scoliosis X-rays for global sagittal alignment assessment; bone density DEXA scan (especially if instrumented fusion planned in patients over 60); PET-CT or bone scan (oncological cases); CT chest/abdomen/pelvis for metastatic staging; blood panel: CBC, CMP, coagulation profile, ESR/CRP, HbA1c (target <7.5% for elective surgery), blood group and crossmatch; anaesthesia fitness assessment including echocardiogram (ECHO) for patients with cardiac history
• CONTRAINDICATIONS (ABSOLUTE): Active systemic infection or bacteraemia not controlled by antibiotics; coagulopathy uncorrectable to INR <1.5; severe cardiopulmonary compromise with ASA Class V status; patient refusal of blood transfusion without agreed bloodless surgery protocol
• CONTRAINDICATIONS (RELATIVE): Severe osteoporosis (T-score < −3.5) requiring augmentation strategies; multilevel disease spanning >3 segments requiring staged procedures; prior extensive spinal hardware making revision technically complex; active tobacco use (strongly advise cessation ≥6 weeks pre-op to optimise fusion rates)
Procedure
ANTERIOR CERVICAL CORPECTOMY AND FUSION (ACCF): The workhorse approach for 1–3 level cervical disease. The surgeon accesses the cervical spine through a transverse anterolateral neck incision (Smith-Robinson corridor), removes the pathological vertebral body and adjacent discs under operative microscope magnification, achieves 360-degree spinal cord decompression, and reconstructs the anterior column with a titanium mesh cage (TMC) or expandable cage packed with autograft or allograft bone. Anterior cervical plating with locking screws completes stabilisation. For single-level disease, fusion rates exceed 95% at 12 months. For 3-level corpectomy, posterior supplemental instrumentation is recommended to reduce pseudarthrosis risk.
POSTERIOR TRANSPEDICULAR CORPECTOMY (PTCA): Performed via a posterior midline approach with multilevel pedicle-screw and rod instrumentation placed first to maintain stability throughout decompression. The vertebral body is accessed by removing the ipsilateral pedicle(s) and lateral vertebral body wall. PTCA avoids anterior approach morbidity (dysphagia, recurrent laryngeal nerve palsy) and allows simultaneous 360-degree fusion in a single surgical position. Navigation (Stealth Station, BrainLab) and robotic assistance (Mazor X, ROSA) are standard at GAF partner institutions, reducing pedicle breach rates to <2%.
LATERAL EXTRACAVITARY AND EXTREME LATERAL (XLIF/LLIF) CORPECTOMY: Retroperitoneal or thoracoscopic lateral approaches (e.g., XLIF — Extreme Lateral Interbody Fusion) provide access to the thoracolumbar vertebral bodies while avoiding the major vessels of the anterior approach. These platforms accommodate specialised lateral corpectomy cages and carry significantly reduced blood loss compared to open anterior thoracotomy. Particularly favoured for T5–L4 pathology in oncological and infectious cases.
MINIMALLY INVASIVE SPINE (MIS) CORPECTOMY: MIS tubular-retractor or expandable-access corpectomy using the Minimally Invasive Lateral approach reduces muscle trauma, blood loss (mean intraoperative blood loss 350–600 mL vs. 800–1500 mL open), hospital stay (average 4–5 days vs. 7–10 days), and infection risk. Intraoperative CT-guided navigation (O-arm Imaging System) enables real-time confirmation of decompression adequacy and implant position without open-field direct visualisation, making MIS corpectomy safe even in complex revision cases.
ROBOTIC-ASSISTED CORPECTOMY: Platforms such as the Mazor X Stealth Edition and Globus ExcelsiusGPS integrate CT/fluoroscopy-based preoperative planning with robotic arm guidance for submillimetre pedicle screw trajectory execution. At high-volume spinal centres in India (Chennai, Mumbai, Hyderabad) and the UAE (Cleveland Clinic Abu Dhabi, Burjeel Medical City), robotic corpectomy is available and produces pedicle screw accuracy rates exceeding 98%, reduced radiation exposure for the surgical team, and reproducible outcomes.
INTRAOPERATIVE NEUROMONITORING (IONM): All corpectomy procedures at GAF partner hospitals are performed under continuous multimodal IONM — SSEPs and MEPs monitored by a dedicated neurophysiologist. A >50% reduction in MEP amplitude or >10% increase in latency triggers a standardised alarm protocol, allowing immediate surgical correction. IONM reduces permanent neurological deficit risk from ~3–5% (historical) to <1.5% in contemporary series.
ANESTHESIA AND BLOOD MANAGEMENT: Total intravenous anaesthesia (TIVA) with propofol/remifentanil is preferred to preserve IONM signal quality. Cell-salvage autotransfusion (Cell Saver) and tranexamic acid (TXA) infusion protocol reduce allogenic blood transfusion rates. Controlled hypotensive anaesthesia (MAP 60–70 mmHg) limits field haemorrhage while spinal cord perfusion pressure monitoring maintains cord safety margins.
Cost of Corpectomy Surgery: India vs. UAE
The cost of corpectomy surgery varies significantly depending on the number of vertebral levels involved, the surgical approach (anterior, posterior, or combined 360-degree), the type of implant system used (expandable cage vs. standard titanium mesh cage), robotic navigation utilisation, and the hospital tier selected. India offers the same evidence-based surgical protocols, implant brands (Depuy Synthes, Medtronic, Globus Medical), and neuromonitoring standards as Western hospitals at approximately 40–60% of UAE costs — primarily due to lower overhead, nursing labour, and hospital administrative costs. The UAE, while significantly more expensive, offers ultra-premium hospital environments, multilingual concierge medical services, and direct flight connectivity from GCC countries, Europe, and Africa that may justify the premium for certain patient profiles. Both destinations provide internationally accredited care; the choice is fundamentally one of budget, geography, and lifestyle preference during recovery.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $5,500 – $12,000 | ~58% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $14,000 – $28,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — PRE-TRAVEL CONSULTATION (Weeks −6 to −3): Patient submits MRI, CT, operative reports, and clinical summary to GAF Healthcare's case management team. A board-certified spinal neurosurgeon or orthopaedic spine surgeon at the selected partner hospital reviews the case within 48–72 hours and provides a detailed surgical plan, cost estimate, and pre-operative optimisation checklist. Telemedicine video consultation is arranged for patient and family. Optimisation targets: HbA1c <7.5%, cessation of anticoagulants (warfarin stopped 5 days pre-op; DOACs stopped 48–72 hours pre-op per bridging protocol), cessation of NSAIDs 7 days pre-op, autologous blood donation considered for high blood-loss cases.
PHASE 2 — ARRIVAL AND PRE-OPERATIVE WORKUP (Days −2 to −1): GAF Healthcare coordinates airport pickup, hotel or hospital guest-house accommodation for patient and attendant. On Day −1, patient is admitted for final workup: repeat blood panel, anaesthesia assessment, CT/MRI review with surgical team, consent process, bowel preparation if thoracolumbar approach planned, prophylactic LMWH (enoxaparin) protocol initiated post-admission. Surgical team briefing including IONM neurophysiologist, scrub nurse, and implant representative is completed.
PHASE 3 — SURGICAL DAY (Day 0): Procedure duration: 3–7 hours depending on number of levels and approach. Sequence: general anaesthesia induction → IONM baseline recording → patient positioning (supine with Gardner-Wells traction for cervical; prone with Jackson table for posterior thoracolumbar) → navigation registration (CT or fluoroscopy-based) → approach, exposure → corpectomy (removal of vertebral body with high-speed burr, Kerrison rongeurs, ultrasonic bone aspirator [CUSA]) → decompression confirmed under microscopy → cage sizing and insertion → autograft/allograft packing → anterior plate or pedicle screw-rod instrumentation → intraoperative C-arm or O-arm fluoroscopy to confirm implant position and canal clearance → wound closure in layers → post-operative CT prior to extubation if indicated.
PHASE 4 — ICU AND EARLY WARD RECOVERY (Days 1–4): ICU stay: 1–2 days for neurological observation, haemodynamic stability, pain management (multimodal analgesia: IV paracetamol, ketorolac, opioid PCA, gabapentin). DVT prophylaxis initiated within 24–48 hours. Drain removal Day 1–2 when output <50 mL/8hr. Physiotherapy commences Day 1: bedside breathing exercises, ankle pumps. Cervical or thoracolumbar orthosis fitted and mobilisation begins with physiotherapist support Day 2–3. Dysphagia assessment (speech therapy) for anterior cervical cases.
PHASE 5 — WARD REHABILITATION (Days 5–10): Progressive ambulation with walking frame, then independent. Stair training. Occupational therapy for upper limb ADL retraining in myelopathic patients. Discharge planning: wound check, brace instructions, medication reconciliation (proton pump inhibitor, vitamin D 1000 IU/day, calcium 1200 mg/day, bone health optimisation with zoledronic acid considered if osteoporotic).
PHASE 6 — POST-DISCHARGE RECOVERY IN COUNTRY (Weeks 2–6): Patient remains in-country for 4–6 weeks for wound review (staple/suture removal Day 12–14), post-operative CT/MRI to confirm decompression and hardware position (typically Week 4–6), and supervised outpatient physiotherapy. Neurological recovery trajectory is monitored via serial mJOA scoring. During this period, light walking is encouraged; lifting >2 kg, bending, and twisting are restricted.
PHASE 7 — FIT-TO-FLY CLEARANCE (Weeks 4–8): Short-haul flight (under 4 hours): typically cleared at 4–5 weeks with cervical or lumbar brace, aisle seat, compression stockings, and aspirin or LMWH. Long-haul intercontinental flight: cleared at 6–8 weeks after surgeon review, with mandatory ambulation every 45–60 minutes and compression hosiery. GAF Healthcare provides a medical fitness-to-fly certificate and travel health summary for the patient's home physician.
PHASE 8 — LONG-TERM RECOVERY MILESTONES: Week 6: Return to sedentary work, driving (if not on opioids and brace discontinued by surgeon). Month 3: CT/X-ray fusion assessment; light gym activity permitted. Month 6: Full functional activity typically restored; mJOA reassessment; fusion confirmed in majority. Month 12–24: Final fusion assessment; bone densitometry if osteoporotic; neurological plateau evaluation.
Risks & Considerations
Corpectomy is a technically demanding procedure with a well-characterised risk profile that patients must understand comprehensively before making an informed decision. Neurological deterioration — the most feared complication — occurs in 1–3% of cases despite IONM; this may be transient (neuropraxia) or, rarely, permanent motor deficit. Pseudarthrosis (failure of bony fusion) affects 5–15% of multilevel cases without supplemental posterior fixation and may require revision surgery. Implant-related complications include cage migration or subsidence (more common in osteoporotic bone; mitigated by DEXA-guided implant selection and post-operative bisphosphonate therapy) and screw pullout. Approach-specific risks for anterior cervical corpectomy include dysphagia (10–20%, usually transient), hoarseness from recurrent laryngeal nerve traction (3–5%), Horner's syndrome (<1%), and vascular injury to the vertebral artery (<0.5%). Thoracolumbar anterior approaches carry risks of injury to the segmental vessels, sympathetic chain, ureter, and retroperitoneal structures. Posterior approaches risk dural tear with CSF leak (1–4%), epidural haematoma, and wound dehiscence. Systemic risks include deep vein thrombosis and pulmonary embolism (mitigated by LMWH protocol and pneumatic compression devices), pulmonary complications (atelectasis, pneumonia — especially after thoracotomy), and surgical site infection (1–2% in posterior instrumented cases). Patients with diabetes, immunosuppression, or malnutrition face elevated infection and poor-healing risk and require pre-operative optimisation. Blood loss can be significant (mean 500–1500 mL depending on approach and pathology); cell salvage and TXA protocols at GAF partner centres substantially reduce transfusion requirements. Adjacent segment disease — accelerated degeneration above or below the fusion construct — is a long-term consideration, with clinically significant disease occurring in approximately 3% of patients per year over 10 years, occasionally requiring further surgery.
Top Hospitals for Corpectomy Surgery
Frequently Asked Questions — Corpectomy Surgery
Corpectomy surgery in India is estimated to cost between USD 5,500 and USD 12,000 for a complete package including surgeon fees, anaesthesia, intraoperative neuromonitoring (IONM), implant (titanium cage and instrumentation), ICU stay, ward stay of 7–10 days, post-operative imaging, and standard medications. The wide range reflects the number of vertebral levels resected (single-level is at the lower end; 3-level or combined anterior-posterior 360-degree procedures approach the upper range), the choice of instrumentation system, and the hospital tier — JCI-accredited tertiary centres in Chennai, Mumbai, Hyderabad, and Delhi represent the high end of Indian pricing, while NABH-accredited centres offer competitive rates without compromising on implant quality or surgical expertise. In the UAE (Dubai and Abu Dhabi), the estimated cost ranges from USD 14,000 to USD 28,000 for an equivalent clinical package, with the higher cost driven by premium hospital infrastructure, nursing ratios, and consumables pricing at JCI- and DHA-licensed facilities such as Cleveland Clinic Abu Dhabi, Burjeel Medical City, and Mediclinic City Hospital. India is therefore approximately 50–60% less expensive than the UAE for this procedure. Both destinations provide the same internationally accredited surgical implant brands (Depuy Synthes, Medtronic, Globus Medical) and neuromonitoring standards. GAF Healthcare provides a transparent, itemised cost estimate for both destinations before the patient commits to any booking, with no hidden facility or coordination fees.
You should plan to stay in India or the UAE for a minimum of 4–6 weeks after your corpectomy surgery, and in some cases up to 8 weeks, before you are medically cleared for an international flight. The specific timeline depends on the surgical approach, number of levels operated, your neurological recovery trajectory, and the distance of your home flight. During your hospital stay of 5–10 days (including 1–2 nights in the ICU), your surgical team will assess neurological stability, wound healing, and your ability to mobilise safely. After discharge from hospital, you will continue outpatient physiotherapy and attend a critical post-operative CT or MRI appointment (typically at Week 4–6) to confirm adequate spinal cord decompression and hardware positioning before clearance for travel. For short-haul flights under 4 hours, most surgeons will clear you at 4–5 weeks post-operatively, provided you travel in an aisle seat, wear graduated compression stockings, ambulate every 45–60 minutes during the flight, and follow a thromboprophylaxis protocol (aspirin or low-molecular-weight heparin) as prescribed. For long-haul intercontinental flights — particularly relevant for patients travelling back to the UK, USA, Canada, Australia, or sub-Saharan Africa — clearance is typically at 6–8 weeks, after the surgeon has reviewed your recovery in person and confirmed that the risk of in-flight thromboembolism and spinal destabilisation is acceptably low. GAF Healthcare issues a formal medical fitness-to-fly certificate at the time of clearance, which your airline may request. We strongly advise against booking non-refundable return flights in advance of your surgeon's clearance.
The success rate of corpectomy surgery depends on how 'success' is defined clinically — and it is important to give you a precise, multi-dimensional answer. For neurological improvement, defined as at least one grade of improvement on the modified Japanese Orthopaedic Association (mJOA) scale or Nurick Grade, published literature reports success in 85–93% of patients with cervical spondylotic myelopathy at 12-month follow-up. Neurological recovery is most robust when surgery is performed before permanent cord signal changes appear on MRI (T2 intramedullary hyperintensity), underscoring the importance of timely intervention. For bony fusion — confirmed by CT at 12–24 months — fusion rates exceed 95% in single and two-level corpectomy with modern titanium expandable cage constructs and pedicle-screw instrumentation, rising further with posterior supplemental fixation in multilevel cases. For pain relief and functional improvement, over 87% of patients report significant reduction in axial neck or back pain and improved extremity function at one-year assessment. In oncological corpectomy — where the goal is local tumour control, neurological preservation, and structural stability rather than cure — over 80% of appropriately selected patients maintain ambulatory status and experience meaningful pain reduction during their survival period. Implant-related failure (cage migration, pseudarthrosis) occurs in approximately 3–8% of cases and may require revision. Patient-specific factors that significantly influence outcomes include pre-operative neurological status (the more severe and prolonged the deficit, the less complete the recovery), bone density (osteoporosis increases subsidence risk), diabetes, smoking history, and the precision of surgical execution — the latter being directly linked to the experience of the surgical team and the availability of intraoperative neuromonitoring and navigation technology, both of which are standard at GAF Healthcare's partner institutions in India and the UAE.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides a fully integrated non-medical support pathway designed to eliminate logistical barriers for international patients undergoing corpectomy.
INDIA — VISA AND ENTRY: GAF facilitates the e-Medical Visa (eMV) application for India, available to citizens of 156+ eligible countries. The eMV is granted for up to 60 days and is double-entry, accommodating patients who may need staged procedures or extended post-operative stays. GAF's documentation team prepares the hospital invitation letter, cost estimate, and medical summary in the format required by Indian missions, achieving typical approval within 3–5 business days. Accompanying attendants apply for the e-Medical Attendant Visa (eMAV).
UAE — VISA AND ENTRY: Citizens of GCC countries, the EU, UK, USA, Australia, and 50+ additional nationalities receive a visa-on-arrival or free visa-free entry to the UAE for 30–90 days. For nationalities requiring advance visas, GAF coordinates the UAE medical visa through the selected hospital's international patient department (linked to ICA — Federal Authority for Identity), which expedites processing to 48–72 hours with hospital sponsorship. No additional travel insurance or surety bond is typically required.
AIRPORT AND GROUND TRANSFERS: All ground transfers — international airport arrival, hotel, hospital, and airport departure — are coordinated by GAF's local operations teams in India (Delhi, Mumbai, Chennai, Hyderabad, Bangalore) and the UAE (Dubai, Abu Dhabi). Vehicles are wheelchair-accessible and equipped for post-spinal-surgery patients who may be in a brace or have limited mobility. A dedicated patient coordinator meets the patient at the arrivals hall.
TRANSLATION AND INTERPRETATION: GAF maintains a network of certified medical interpreters covering Arabic, Russian, French, Swahili, Bengali, and 20+ additional languages in both India and the UAE. Interpreters are present at all key touchpoints: surgical consent, anaesthesia consultation, physiotherapy briefings, and discharge planning.
ACCOMMODATION FOR PATIENT AND ATTENDANT: For the 4–8 week in-country recovery period, GAF Healthcare arranges serviced apartment accommodation or hospital guest-house options within 5–15 minutes of the treating hospital, negotiated at preferential rates. Attendant-friendly rooms include kitchenette facilities for dietary-restricted patients (post-operative soft diet requirements for anterior cervical corpectomy patients) and 24-hour security. For UAE-based treatment, accommodation options range from 3-star medical hotel partnerships to 5-star concierge medical suites per patient preference.
CONTINUITY OF CARE AFTER RETURN: GAF Healthcare provides every patient with a structured medical discharge dossier — operative report, implant serial numbers (essential for airport metal detector exemption certificates), post-operative imaging, rehabilitation protocol, and medication schedule — formatted for direct handover to the patient's home physiotherapist and primary care physician. Telemedicine follow-up appointments with the operating surgeon at Weeks 6 and 12 are included as standard.